Laboratoires Théa
Luc Lebreton is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as the Responsable Innovation at Laboratoires Théa since April 2020. Prior roles include R&D Project Director at AzurRx BioPharma, R&D Programs Director at Eyevensys, and Therapeutic Area Projects Leader at Abbott Laboratories. Luc has a strong background in leading R&D programs, particularly in gene therapy and gastrointestinal treatments, and has held strategic positions at Solvay Pharmaceuticals and Laboratoires Fournier, among others, focusing on projects from exploratory targets to proof of concept. Luc obtained a PhD in Pharmacochemistry from Université Pierre et Marie Curie.
This person is not in any teams
This person is not in any offices
Laboratoires Théa
2 followers
Laboratoires Théa is a pharmaceutical industry specialized in ophthalmology. The group is the leader in several therapeutic classes as well as in the field of preservative-free eye drops. Laboratoires Théa is an innovative company dedicated to developing high-quality products that support ophthalmic care and eye health across more than 70 countries.